(Q57152185)
Statements
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study (English)
C Bokemeyer
J T Hartmann
G Schuch
A Zubel
I Celik
M Schlichting